Feb. 4 at 3:25 AM
$NBIX $NTRP $NXTC $NGM $NITE
Pharma vaccine companies dont like this company.
Yesterday they recieved 14mil grant from Health of Canada to complete stage 2 trials Prime Minister talked about it on National TV
4 days ago FDA and Health of CANADA approved sub study for EBO5 COVID 19 Treatments forSICK ICU patients.
Short summary of the company.
Reverse merge with Stellar in June 2019
CEO successful business background
Market cap
$70 million
Insiders own more than %50 of shares
Low float ONLY 3.9 million
NO DEBT
$7 mil cash on hand
ARDS/Covid antibody drug EB05
Health Canada and FDA approval Phase 2
EB05 Drug already manufactured 👈👈
Manufacturer (Light Chain Bio) located in Europe (Swiss )
Phase 2 trials in 3 different countries.👈👈
Canada, USA and Colombia via JSS Research Org.
Phase 2 results and Fund news coming soon.
They have other drugs in their pipelines. 👈👈
some quick links below Meet the CEO conference on Nov 6.
edesabiotech.com/clinical-p...
twitter.com/EdesaBiotech